Nearly everyone with multiple myeloma relapses. That doesn’t make it easy. A cancer diagnosis is traumatic, especially when the cancer is treatable, but not curable. In multiple myeloma, the disease ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

ctDNA is a valuable prognostic biomarker for relapse in early-stage BTC, outperforming carbohydrate antigen 19-9 levels. ctDNA monitoring can detect molecular recurrence earlier than standard ...

Remote interventions for alcohol or drug use disorder led to a reduction in relapse rates by 39% and the mean number of days of substance use when supplementing in-person care, but effectiveness ...

The FDA has approved Johnson & Johnson’s supplemental new drug application for Caplyta among patients with schizophrenia at ...

Every experience leaves a trace in the brain, a memory that can shape future behavior. Alcohol and other addictive substances ...

The FDA has updated the label for Caplyta to include phase 3 data showing a significant reduction in schizophrenia relapse risk.

Every-6-month dosing of the long-acting injectable paliperidone palmitate (Invega Hafyera) for schizophrenia was effective and safe up to 3 years, researchers reported during a poster presentation at ...

Wellbrook Recovery is a premier, high-quality, Wisconsin addiction treatment center, providing a unique recovery experience for those struggling with substance use. We offer a full continuum of care, ...